ABERNETHY MATT Insider Trades

Insider Trading History

Track insider trading activity for ABERNETHY MATT. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $190k 87,900 shares
Last Trade
Jun 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$181k 87,900 shares
$2.06
$2.16
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $6.91M 42,808 shares
Last Trade
Mar 04, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$300k 2,249 shares
$133.44
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $1.25M 7,735 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$959k 7,735 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $7.25M 44,881 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$668k 5,378 shares
$124.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $6.5M 40,291 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$172k 1,385 shares
$124.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $6.73M 41,676 shares
Last Trade
Feb 13, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$318k 2,566 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $6.51M 40,320 shares
Last Trade
Feb 13, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$278k 2,241 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $7.12M 44,095 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.47M 44,095 shares
$124.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $8.11M 50,259 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.24M 9,968 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $414k 2,566 shares
Last Trade
Feb 13, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$318k 2,566 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $724k 4,484 shares
Last Trade
Feb 13, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$278k 2,241 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $6.31M 39,110 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$150k 1,210 shares
$124.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $6.15M 38,079 shares
Last Trade
Feb 12, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$142k 1,151 shares
$123.10
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $6.33M 39,230 shares
Last Trade
Feb 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$263k 2,133 shares
$123.10
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $1.03M 6,401 shares
Last Trade
Feb 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$263k 2,133 shares
$123.10
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $6.21M 38,465 shares
Last Trade
Jan 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$332k 2,437 shares
$136.06
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $5.99M 37,097 shares
Last Trade
Jan 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$186k 1,368 shares
$136.06
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jan 31, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$332k 2,437 shares
$136.06
$161.44
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $238k 110,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$145k 110,000 shares
$1.32
$2.16
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Financial Officer
Holding Value $5.78M 35,810 shares
Last Trade
Feb 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$299k 2,558 shares
$116.86
$161.44

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up